After-Hours Movers 10/13: CNO, MYRX, VOXX, INTC, GPI, CSX Higher; BMTI, PURE Lower
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) 16% LOWER; announced positive top-line results from its North American pivotal (Phase III) randomized controlled trial comparing its fully synthetic, off-the-shelf bone growth factor product, Augment Bone Graft, to autograft for use in hindfoot and ankle fusion surgery. Click here for the full report.
Conseco, Inc. (NYSE: CNO) 14.2% HIGHER; announced today that, as part of a series of transactions intended to enhance its capital position, it entered into a stock and warrant purchase agreement with John Paulson's Paulson & Co. Inc., on behalf of the several investment funds and accounts managed by it, to sell to Paulson 16.4 million shares of common stock and warrants to purchase 5.0 million shares of common stock for an aggregate purchase price of $77.9 million. Click here for the full report.
Myriad Pharmaceuticals, Inc. (Nasdaq: MYRX) 8% HIGHER; today announced the identification of an Investigational New Drug candidate targeting a novel molecular target, the protein kinase IKK epsilon. Click here to see the full report.
Audiovox Corporation (Nasdaq: VOXX) 6.1% HIGHER; reports Q2 EPS of $0.12, compared to a loss of $0.10 in the same quarter last year. Revenue for the quarter was $124.9 million, versus $147.2 million in Q209.
Intel Corporation (Nasdaq: INTC) 4.6% HIGHER; reports Q3 EPS of $0.33, 6 cents better than the analyst estimate of $0.27. Revenue for the quarter was $9.4 billion, which compares to the estimate of $9.02 billion. Sees Q4 sales of $10.1 billion plus or minus $400 million.
Group 1 Automotive, Inc. (NYSE: GPI) 4.5% HIGHER; today reported that based on preliminary results, it expects 2009 third-quarter diluted earnings per share within a range of $0.68 to $0.72. This range excludes a one-time tax adjustment that is estimated to add approximately $0.07 per diluted share, gains on debt redemption of approximately $0.02 per diluted share and non-cash impairment charges primarily related to real estate holdings of approximately $0.02 per diluted share.
PURE Bioscience (NASDAQ: PURE) 3.3% LOWER; reports FY09 loss of $0.23, compared to a loss of $0.24 in the same quarter last year. Revenue for the year was $728,300, versus $1.49 million in '08.
CSX Corporation (NYSE: CSX) 2.4% HIGHER; reports Q3 EPS of $0.74, 3 cents better than the analyst estimate of $0.71. Revenue for the quarter was $2.3 billion, which compares to the estimate of $2.32 billion.
Altera Corporation (Nasdaq: ALTR) 2.2% HIGHER; reports Q3 EPS of $0.19, inline with the analyst estimate of $0.19. Revenue for the quarter was $286.6 million, which compares to the estimate of $283.27 million. Sees Q4 sales growth up 6-10% from Q3, gross margin of 67-68%.
Linear Technology (Nasdaq: LLTC) 1.8% HIGHER; reports Q1 EPS of $0.29, ex-items, 5 cents better than the analyst estimate of $0.24. Revenue for the quarter was $236.1 million, which compares to the estimate of $215.87 million.
To get this report daily, visit http://www.streetinsider.com/entities/After-Hours+Movers.
Create E-mail AlertRelated Categories
Special ReportsStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
